The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 06, 2024

Filed:

Sep. 23, 2019
Applicant:

The United States of America, As Represented BY the Secretary, Department of Health and Human Services, Bethesda, MD (US);

Inventors:

Peter Kwong, Washington, DC (US);

Li Ou, Potomac, MD (US);

John Mascola, Rockville, MD (US);

Baoshan Zhang, Bethesda, MD (US);

Kai Xu, Rockville, MD (US);

Wing-Pui Kong, Germantown, MD (US);

Yaroslav Tsybovsky, Brunswick, MD (US);

Cara W. Chao, Bethesda, MD (US);

Jeffrey Boyington, Clarksburg, MD (US);

Yiran Wang, Bethesda, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/21 (2006.01); A61K 9/16 (2006.01); A61K 39/00 (2006.01); A61K 39/12 (2006.01); A61K 47/64 (2017.01); A61K 47/69 (2017.01); A61P 31/18 (2006.01);
U.S. Cl.
CPC ...
A61K 39/21 (2013.01); A61K 9/1658 (2013.01); A61K 47/64 (2017.08); A61K 47/644 (2017.08); A61K 47/646 (2017.08); A61K 47/6925 (2017.08); A61P 31/18 (2018.01); A61K 2039/6031 (2013.01); A61K 2039/6037 (2013.01); A61K 2039/6068 (2013.01); A61K 2039/6075 (2013.01); A61K 2039/6081 (2013.01); A61K 2039/645 (2013.01);
Abstract

Embodiments of immunogenic conjugates including the HIV-1 Env fusion peptide and methods of their use and production are disclosed. In several embodiments, the immunogenic conjugates can be used to generate an immune response to HIV-1 Env in a subject, for example, to treat or prevent an HIV-1 infection in the subject.


Find Patent Forward Citations

Loading…